Horizon Pharma (HZNP) Tops Q3 EPS by 30c; Boosts FY15 Revenue Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. CSX
7. LRCX
8. MRK
9. LVS
10. SAP

Go back to Horizon Pharma (HZNP) Tops Q3 EPS by 30c; Boosts FY15 Revenue Outlook

Horizon Pharma plc Announces Exceptional Third-Quarter 2015 Financial Results and Significantly Raises Full-Year 2015 Sales and Adjusted EBITDA Guidance

November 6, 2015 7:00 AM EST

DUBLIN, IRELAND -- (Marketwired) -- 11/06/15 -- Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced its third-quarter 2015 financial results today.

Quarterly Financial Highlights

(in millions except for per share amounts and % % percentages) Q3 15 Q3 14 Change 9M 15 9M 14 Change --------- --------- ------- --------- --------- ------- Net sales $ 226.5 $ 75.1 202 $ 512.5 $ 193.1 165 Net income (loss) 3.3 2.1 57 15.5 (232.0) NM Adjusted non-GAAP net income 117.0 19.4 503 203.4 46.2 340 Adjusted EBITDA 131.1 22.1 493 239.7 52.3 358 Earnings (loss) per share - basic $ 0.02 $ 0.03 -33 $ 0.11 $ (3.17) NM Adjusted non-GAAP earnings per share - basic 0.74 0.25 196 1.40 0.63 122 Earnings (loss)... More